Home › Employers › Clarewood House Inc
Clarewood House Inc: H-1B salaries and sponsorship
Clarewood House Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 4. Median offered salary: $84,895.
Does Clarewood House Inc sponsor H-1B visas?
Clarewood House Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Mar 25, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Treatment Nurse Manager | 2 | $84,895 |
| Treatment Nurse | 1 | $73,050 |
| Administrator of Health Service | 1 | $144,144 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2023 | 1 | $74,110 |
| FY2025 | 2 | $84,365 |
| FY2026 | 1 | $144,144 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Administrator of Health Service | $144,144 Level II | Houston, TX | Mar 25, 2026 | Apr 1, 2026 | Certified |
| Treatment Nurse Manager | $95,680 Level I | Houston, TX | Sep 3, 2025 | Mar 1, 2026 | Certified |
| Treatment Nurse | $73,050 Level I | Houston, TX | Apr 14, 2025 | May 1, 2025 | Certified |
| Treatment Nurse Manager | $74,110–$97,074 Level I | Houston, TX | Oct 6, 2022 | Mar 1, 2023 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).